ArticlePDF Available

Optimization of ERK Activity Biosensors for both Ratiometric and Lifetime FRET Measurements

Authors:

Abstract and Figures

Among biosensors, genetically-encoded FRET-based biosensors are widely used to localize and measure enzymatic activities. Kinases activities are of particular interest as their spatiotemporal regulation has become crucial for the deep understanding of cell fate decisions. This is especially the case for ERK, whose activity is a key node in signal transduction pathways and can direct the cell into various processes. There is a constant need for better tools to analyze kinases in vivo, and to detect even the slightest variations of their activities. Here we report the optimization of the previous ERK activity reporters, EKAR and EKAREV. Those tools are constituted by two fluorophores adapted for FRET experiments, which are flanking a specific substrate of ERK, and a domain able to recognize and bind this substrate when phosphorylated. The latter phosphorylation allows a conformational change of the biosensor and thus a FRET signal. We improved those biosensors with modifications of: (i) fluorophores and (ii) linkers between substrate and binding domain, resulting in new versions that exhibit broader dynamic ranges upon EGF stimulation when FRET experiments are carried out by fluorescence lifetime and ratiometric measurements. Herein, we characterize those new biosensors and discuss their observed differences that depend on their fluorescence properties.
Content may be subject to copyright.
Sensors 2014, 14, 1140-1154; doi:10.3390/s140101140
sensors
ISSN 1424-8220
www.mdpi.com/journal/sensors
Article
Optimization of ERK Activity Biosensors for both Ratiometric
and Lifetime FRET Measurements
Pauline Vandame 1,2, Corentin Spriet 2, Franck Riquet 1,2, Dave Trinel 2, Katia Cailliau-Maggio 1
and Jean-François Bodart 1,2,*
1 Laboratoire de Régulation des Signaux de division, EA4479, Institut Fératif de Recherche (IFR) 147,
Site de Recherche Intégré en Cancérologie (SIRIC) ONCOLILLE, University Lille1,
Villeneuve d’Ascq F-59655, France; E-Mails: pauline.vandame@ed.univ-lille1.fr (P.V.);
franck.riquet@iri.univ-lille1.fr (F.R.); Katia.Maggio@univ-lille1.fr (K.C.-M.)
2 Interdisciplinary Research Institute, USR3078 CNRS, Université Lille Nord de France,
50 avenue de Halley, Villeneuve d’Ascq Cedex F-59558, France;
E-Mails: corentin.spriet@iri.univ-lille1.fr (C.S.); dave.trinel@iri.univ-lille1.fr (D.T.)
* Author to whom correspondence should be addressed; E-Mail: Jean-Francois.Bodart@univ-lille1.fr;
Tel.: +33-3-2043-6867.
Received: 8 November 2013; in revised form: 6 December 2013 / Accepted: 19 December 2013 /
Published: 10 January 2014
Abstract: Among biosensors, genetically-encoded FRET-based biosensors are widely used
to localize and measure enzymatic activities. Kinases activities are of particular interest as
their spatiotemporal regulation has become crucial for the deep understanding of cell fate
decisions. This is especially the case for ERK, whose activity is a key node in signal
transduction pathways and can direct the cell into various processes. There is a constant
need for better tools to analyze kinases in vivo, and to detect even the slightest variations of
their activities. Here we report the optimization of the previous ERK activity reporters,
EKAR and EKAREV. Those tools are constituted by two fluorophores adapted for FRET
experiments, which are flanking a specific substrate of ERK, and a domain able to
recognize and bind this substrate when phosphorylated. The latter phosphorylation allows a
conformational change of the biosensor and thus a FRET signal. We improved those
biosensors with modifications of: (i) fluorophores and (ii) linkers between substrate and
binding domain, resulting in new versions that exhibit broader dynamic ranges upon EGF
stimulation when FRET experiments are carried out by fluorescence lifetime and
ratiometric measurements. Herein, we characterize those new biosensors and discuss their
observed differences that depend on their fluorescence properties.
OPEN ACCESS
Sensors 2014, 14 1141
Keywords: genetically-encoded biosensor; ERK; FRET
Abbreviation List
72 gly: 72-glycine linker
AKAR3: A Kinase Activity Reporter 3
AKAR4: A Kinase Activity Reporter 4
cAMP: cyclic Adenosine Mono Phosphate
CFP: Cyan Fluorescent Protein
CpVenus172: Circularly permutated Venus in position 172
eCFP: Enhanced Cyan Fluorescent Protein
EGF: Epidermal Growth Factor
eGFP: enhanced Green Fluorescent Protein
EKAR: Extracellular signal-regulated Kinase Activity Reporter
EKAR-Cer-CpV: EKAR-Cerulean-Circularly permutated Venus
EKAREV: Extracellular signal-regulated Kinase Activity Reporter Enhanced Visualization
EKAREV-TVV: EKAREV-Turquoise-CpVenus-Venus
EKAR-TVV: EKAR-Turquoise-CpVenus-Venus
FHA2: Forkhead-Associated 2
FLiM: Fluorescence Lifetime Imaging Microscopy
FP: Fluorescent Protein
FRET: Förster Resonance Energy Transfer
GFP: Green Fluorescent Protein
KSR: Kinase Suppressor of Ras
MAPK/ERK: Mitogen Activated Protein Kinase/ Extracellular signal-regulated kinase
MAPK: Mitogen Activated Protein Kinase
MEK: MAPK/ERK protein Kinase
Miu2: MAPK Indicator Unit ERK2
NGF: Nerve Growth Factor
PAABD: PhosphoAminoAcid Binding Domain
PKA: Protein Kinase A
TEPACVV: Turquoise Exchange Protein directly Activated by cAMP CpVenus-Venus
WW domain: Tryptophan (W) repeated domain
YFP: Yellow Fluorescent Protein
1. Introduction
How a cell can integrate numerous external signals to elicit a specific and adapted response with
only a limited number of signaling effectors remains a puzzling question. These effectors are finely
tuned and regulated by post-translational modifications, including phosphorylation, which in turn is
able to control subcellular localization and activity. Intensity and duration of the phosphorylation
Sensors 2014, 14 1142
depend on the equilibrium between the activities of kinases and phosphatases, as well as on the
crosstalk and connectivity established between pathways. All together, these parameters ensure
appropriate and specific cell decisions.
Among the signaling cascades of phosphorylated molecules, which are dedicated to conveying
information and integrating extracellular signals, the Mitogen Activated Protein Kinase (MAPK)
signaling network stands out [1,2]. Each MAPK signaling chain is a three tier cascade in which the
upstream kinase (MEKK) phosphorylates and activates a second one (MEK), which in turn,
phosphorylates and activates a third kinase (MAPK). The MAPK/ERK cascade successively enrolls
MOS or Raf, MEK1/2, Extracellular Regulated Kinase (ERK) 1/2 that activates by phosphorylation a
plethora of substrates within the cytoplasm and the nucleus, as effectors involved in the physiological
response and phenotypical outcome. These substrates include transcription factors, kinases and
phosphatases, signaling proteins, cytoskeletal proteins, proteinases and apoptotic proteins [3]. These
substrates can be expressed in a cell specific type manner, but their activation also relies on threshold
effects, therefore, the duration and amplitude of ERK activity level are crucial for signal integration.
Depending upon the presence of feedbacks, the cascade may display different kinds of temporal
responses affecting the resulting phenotypes. Indeed, distinct profiles of ERK activation in response to
different growth factors were revealed in PC12 cells: EGF stimulation leads to a transient ERK
activation, whereas NGF induces a sustained activation [4]. Network rewiring can also drive an abrupt
ERK response in models like Xenopus oocytes, where feedback loops and feedforward loops elaborate
physical properties like ultrasensitivity, bistability and irreversibility [57]. Spatial regulation also
participates in proper signal propagation. Several scaffolding proteins that bind the components of the
MAPKs cascade have been identified. They participate in anchoring the kinases and can promote their
activation in different cell compartments. For example Sef1 localizes MEK on the Golgi membrane
and KSR assembles the three members at the plasma membrane following the pathway stimulation [8].
During the past two decades, new tools have emerged concomitantly to the discovery of GFP.
Among these tools, genetically encoded enzyme activity reporters based on Förster Resonance Energy
Transfer (FRET) imaging have become more and more attractive due to their ability to sense and
report the level of several analytes such as second messengers, ions or protein activity in living cells or
tissues [9]. FRET is a non-radiative energy transfer between a pair of fluorophores. The energy transfer
depends on the spectral overlap between the emission and excitation spectra, and the relative
orientation of the so-called donor and acceptor. This energy transfer can only occur if donor and
acceptor are in close vicinity. Genetically encoded enzyme activity reporters based on FRET are
biosensors, since the latter term include systems composed of at least two parts: one part that
specifically recognized an analyte, and a second part which transduces and conveys the signal from
the recognition site toward an adapted instrument collecting a measurable signal.
Kinase activity biosensors are constituted by two fluorophores adapted for FRET experiments.
Those fluorophores are flanking a specific peptide substrate of ERK and a domain recognizing and
binding this peptide substrate when phosphorylated. The latter recognition allows a conformational
change of the biosensor and thus a FRET signal.
Upon FRET several properties of light are modified and can be measured. The emission intensity of
the donor fluorophore decreases, while emission intensity of the acceptor increases. In this way FRET
can thus be evaluated by dividing the YFP signal by the CFP signal. An increase of this YFP/CFP ratio
Sensors 2014, 14 1143
thus corresponds to an increase of kinase activity and vice versa [10]. The lifetime of the donor
fluorophore is also affected by a FRET event and decreases upon kinase activity.
The purpose of optimizing such tools directly relies on kinase activity behavior. In fact, in some
biological processes, kinase activity changes are too low to be detected with the existing biosensors.
This depends directly on an intrinsic property of the biosensor called the dynamic range, which
corresponds to the maximal difference of ―FRET value‖ between two conditions: when there is no
kinase activity and thus no phosphorylation of the biosensor and when kinases are fully activated and
thus biosensors are folded and give a strong signal. Dynamic range corresponds thus to the ability of
the biosensor to give a measurable FRET signal even when kinase activity is low.
Regarding MAPK/ERK signaling pathway, the first FRET-biosensor designed was named Miu2
(for MAPK Indicator Unit ERK2) [11]. This biosensor used the conformational change of ERK
occurring upon the binding of its activator MEK. Miu2 was made up with a FRET pair (CFP and YFP)
flanking the Xenopus ERK2 sequence, from which they were spaced by short linkers of two and three
aminoacids. When the MAPK/ERK pathway cascade is recruited by an external signal, activated MEK
binds to endogenous ERK as well as the ERK enclosed within the sensor in order to achieve
phosphorylation. This binding lead to a modification of ERK conformation within Miu2, bringing
closer the two fluorophores and therefore noticeably increasing the FRET signal. However, Miu2
expression acts as an overexpression of ERK2, which is a disadvantage because ERK2 overexpression
disturbs cellular processes like in the case of stimulation of proliferation in human hepatocellular
carcinoma study [12]. Moreover if Miu2 reflects MEK activity and MEK-ERK interaction it does not
reflect per se ERK activity. This last issue was resolved in 2007 with the engineering of Erkus [13],
whose principle was quite different from Miu2, since the latter is based on the interaction between a
phosphorylated substrate with a domain recognizing this phosphorylation. Erkus was built using the
same fluorophore pair as Miu2, but these fluorophores were flanking a short amino acid sequence,
corresponding to a specific target of ERK (threonine 669 within the Epidermal Growth Factor
Receptor), followed by the FHA2 (Forkhead-Associated 2) domain, which binds to phosphorylated
threonine residues. Moreover, an ERK docking motif was introduced at the end of the acceptor
fluorophore sequence, to increase the affinity of ERK to the biosensor. Upon ERK activation, the
substrate is phosphorylated and then recognized by the phospho-aminoacid binding domain (PAABD),
leading to a conformational change that allows FRET phenomenon between the fluorophores. Such a
process remains reversible upon the action of specific phosphatases or inhibition of kinase activity [13].
In 2008, another ERK biosensor named Extracellular-regulated Kinase Activity Reporter (EKAR)
was published by Harvey and collaborators [14], taking advantages of the elements of Erkus but
adapting each component. EKAR FRET pair was composed of a CFP variant (mCerulean) and of a
YFP variant (mVenus), since constant progress in FPs engineering allows for an improved FRET
efficiency by changing the fluorophore pair of a biosensor. Alternatively a biosensor was made up
using another couple, eGFP and mRFP. The flanked sequence by the fluorophores includes in that
case: (i) a partial sequence of the Cdc25C substrate containing the threonine 48 residue [2,15]; (ii) a
WW domain, which replaced the FHA2 domain and also recognizes phosphorylated threonine residues
but with an increased affinity for the proline-rich sequence; (iii) a linker constituted of 72 glycine
residues was inserted between these two parts in order to improve the flexibility and favor the folding
of the biosensor. The resulting EKAR revealed higher FRET variation than Erkus and Miu2. Finally in
Sensors 2014, 14 1144
2011, Komatsu and collaborators developed an optimized backbone for the generation of activity
reporters [16]. The major characteristic of this backbone was the development of an improved linker
whose length was optimized in order to favor the energy transfer between the two FRET pairs (e.g.,
ECFP/YPet or Turquoise-GL/YPet). Thus, development of ERK biosensors reflects the constant need
for optimized tools to analyze kinase behaviors during cellular processes. It relies notably on
optimizing their dynamic range. It corresponds to the maximal interval of variation that can be
obtained by measuring the FRET level when there is no kinase activity and upon a strong stimulation
of kinase activity. Thus, an increased dynamic range that allows detecting finer variations will increase
our understanding of protein dynamics and cell fate decisions.
The dynamic range of the preexisting MAPK biosensors to be optimized is directly associated with
FRET efficiency [9], which, in the case of a biosensor, relies: (i) from a structural point of view, on the
folding of the biosensors when phosphorylated/dephosphorylated (i.e., orientation factor, distance
between fluorophores) and (ii) from a photophysical point of view, on the fluorophores properties
(i.e., quantum yield, overlap integral). Two fluorescence properties, modified by FRET, are measured:
fluorescence emission is monitored by ratiometric measurements while fluorescence lifetime is
measured in Fluorescence Lifetime Imaging Microscopy-FRET (FLiM-FRET). Here we report new
ERK biosensors, namely EKAR-Cep-CpV, EKAR-TVV and EKAREV-TVV, modified from the two
last generation of biosensors EKAR and EKAREV [14,16]. Those new probes have been tested and
compared with two different FRET techniques, fluorescence intensity and lifetime based
measurements, in order to provide the most versatile ERK activity biosensor.
2. Experimental Section
2.1. DNA Constructs
Three different constructs were produced based on EKAR and EAKREV sequences [14,16],
taking benefit of recent tandem fluorophores [17,18], and named accordingly to their structural
elements. EKAR-Cer/CpV was generated by subcloning the coding sequence of the molecular
recognition element (eg: docking domain followed by phospho-aminoacid binding domain, 72-Gly
linker and substrate) of prK5 cEKAR [14], inserted between the two fluorophore sequences of the
pcDNA3 AKAR4 [18]. First the AKAR4 coding sequence was sub-cloned into a pCS2 vector using
BamHI/EcoRI. The BamHI unique restriction site of pcDNA3 was deleted by Klenow fill-in. Second,
a BamHI restriction site was reintroduced at the 3' extremity of the Cerulean coding sequence by
site-directed mutagenesis using the 5'-CTGTTCTTGAGAAAACTTATGGATCCGCTTGTACAG
CTCGTCCATG-3' primer. The obtained plasmid contains thus two unique restriction sites BamHI and
SacI flanking the whole sequence between the two fluorophores of AKAR4. The molecular
recognition element of prK5 cEKAR was amplified by PCR using the sense-oligonucleotide 5'-AG
CGGATCCATATGGCGGACGAGGAGAAGC-3' and the antisense-nucleotide 5'-CATGAGCTCGA
TATCCCGGGCCCGCGG-3' containing, respectively, one BamHI and one SacI restriction site. The
resulting fragment was then subcloned into the pCS2 AKAR4 vector using BamHI/SacI enzymes.
Sensors 2014, 14 1145
2.2. EKAR-TVV
This was generated using the same kind of strategy: sub-cloning the sequence of the molecular
recognition element of EKAR [14] between the FRET pair sequence of another biosensor named
TEPACVV [17]. The whole sequence between the fluorophores of the pCDNA3 TEPACVV is surrounded
by two unique restriction enzymes EcoRV and NheI. Because those restriction sites were already
present in the coding sequence of EKAR, we proceed to a multisites-directed mutagenesis to delete
those sites by introducing two silent mutations in EKAR with two primers: 5'-GGAGGAGGAG
GAGCCAGCGGCGG AGGTGG-3' and 5'-GCGGGCCCGGGACATCATGGTGAGCAAGG-3'. The
molecular recognition element sequence of prK5 cEKAR was then amplified by PCR using the
sense-oligonucleotide 5'-CGAT ATCTCCGGATCCATATGGCGGACGAG-3' and the antisense-nucleotide
5'-CGCTAGCGATGTCC CGGGCCCGCGGG-3' containing respectively EcoRV and NheI. The resulting
fragment was then sub-cloned into the pCDNA3 TEPACVV vector.
2.3. EKAREV-TVV
As the FRET pair used in the second construction gives us good results, we tried to optimize it with
an improved linker named EV-linker contained in another MAPK biosensor EKAREV [16]. The major
difference between the two first generations of MAPK biosensors [14,16] consists in a linker variation
between the MAPK subtrate and the WW domain which serves as phosphor amino-acid binding
domain. To obtain a sensor containing both the FRET pair mTurquoise and CpVenus172-Venus and
the EV-linker we amplified the whole sequence surrounded by the fluorophores of EKAR-EV by PCR
using the following primers 5'-CGATATCTCGAGATGGCGGACGAGGAGAAG-3' and 5'-CGCT
AGCGCGG CCGCCCGGAAATTG-3' containing EcoRV and NheI restriction sites, respectively. The
PCR fragment obtained was once again sub-cloned between the fluorophores of the pCDNA3
TEPACVV. The same procedure was used to obtain the negative control sensor. We amplified the
mutated (Threonine to Alanine within the substrate) EKAREV and sub-cloned this fragment into the
pCDNA3 TEPACVV.
2.4. Cell Culture, Transfections and Chemicals
Cells were cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% foetal calf
serum and antibiotics (100 units/mL of penicillin and 100 µg/mL of streptomycin) at 37 °C with 5%
CO2. Cells were seeded on 32 mm coverslips in six-well plates and grown to reach 50% of confluency.
Cells were then transfected with 1 μg of DNA per well using FuGENE HD transfection reagent
(Roche, Mannheim, Germany). Twenty four hours later, cells were starved in DMEM with 0.5% FCS
overnight. Prior to images acquisition, DMEM was removed and cells were placed in L-15 buffered
medium. Epidermal Growth Factor (R&D Systems, Minneapolis, MN, USA) was resuspended in PBS
and used at 100 ng/mL final concentration. MEK inhibitor U0126 dihydrocholride (Sigma, St. Louis,
MO, USA) was resuspended in DMSO and used at the final concentration of 50 μM.
Sensors 2014, 14 1146
2.5. Ratiometric Measurements
Cells on coverslips were placed on a thermostatted (37 °C) inverted Leica AF6000 videomicroscope
(Leica Microsystems, Wetzlar, Germany) with 63, 1.3 numerical aperture (NA) glycerin-immersion
objective. Fluorescence excitation was performed with a 427 ± 10 nm bandpass filter through a double
band dichroic mirror (440/520 nm). To avoid displacements between donor and acceptor’s fluorescence
measurements, we used fast detection filter wheel (respectively with 472 ± 30 nm and 542 ± 27 nm
bandpass filters). Images were acquired every two minutes. After 6 min, drugs were added to the cell
medium by gentle pipetting.
YFP/CFP ratio for cell by cell data analysis was realized with the ImageJ software as described
in [10]. Curves were obtained by subtracting the average of the baseline values (time points 0 to 6 min)
from each time point. Histograms were calculated by subtracting the same average of baseline values
from the average of plateau values after EGF stimulation (points at time 12 to 20 min). In both cases,
average and standard deviation are calculated and represented. p-values were obtained using
Student t-test.
2.6. FLiM Measurements
Frequency domain FLiM experiments were performed using the LIFA system (Lambert
Instruments, Roden, The Netherlands) assembled on a wide field Nikon Eclipse TE2000 inverted
microscope (Nikon, Amsterdam, The Netherlands) in a 37 °C thermostatted chamber and with a 60,
1.4 numerical aperture (NA) oil immersion objective and appropriate CFP filter cube (excitation
426/446 nm; dichroic mirror 455 nm; emission 460/500 nm). The modulation frequency was set to
40 MHz and MCP to 800 V. We used a solution of 7-(diethylamino)coumarin-3-carboxylic acid
(Sigma) diluted in methanol as lifetime reference (4 ns). 36 phases shifted intensity images were
recorded every two minutes, pre-diluted EGF and U0126, according to the experimental designs, were
manually added into the culture medium. Lifetime values were extracted with LiFliM (Lambert
Instruments). For each cell, lifetime variation was obtained by subtracting the average of the baseline
values (time points 0 to 6 min) from each time point. Histograms represent the variation before (time
points 0 to 6 min) and after (1020 min) EGF induction. In both cases the average and standard
deviation is calculated and represented. p-values were obtained using Student t-test.
3. Results and Discussion
The choice of the FRET pairs was guided by previous works on other FRET-based biosensors, one
reporting PKA activity [18] and a second one probing the intracellular cAMP level [17]. Concerning
the PKA activity biosensors, the optimization from A Kinase Activity Reporter 3 (AKAR3) to AKAR4
consisted in a swapping of the donor fluorophores eCFP for the Cerulean FP in combination with a
circularly permutated Venus (in position 172) [18,19]. This change improved the dynamic range of the
biosensor from 38% to 58% in ratio experiments [18]. Therefore, we used the same kind of procedure
on EKAR and exchanged the Venus FP with its variant Cp172 Venus, to obtain a first construction
named EKAR-Cer-CpV, including the Cerulean/cpVenus FRET pair (Figure 1A). TEPACVV is a cAMP
level FRET biosensor that exhibits a remarkable dynamic range. This probe allows one to observe
Sensors 2014, 14 1147
variations up to 700 picoseconds in lifetime experiments and 100% ratio variation upon the stimulation
of cAMP production [17]. Those performances drew our attention on the FRET pair used in this
sensor: A combination of mTurquoise and a dimer cpVenus-Venus. The donor fluorophore is
characterized by a phase lifetime of 3.7 ns (instead of 2.3 for the Cerulean) [20,21], which improves
FLIM measures, while the use of an acceptors dimer also improves ratiometric experiments. We thus
generated a second construction based on this pair and named it EKAR-TVV (Figure 1A).
As the ratiometric techniques is widely used for FRET-based biosensor measurements compared to
FLiM experiments, we choose to first test EKAR-Cer-CpV and EKAR-TVV with this technique. Cells
were starved in order to inhibit ERK activity and then stimulated with Epithelial Growth Factor (EGF).
The difference between the basal ratio values corresponding to starved cells and the ratio values
following EGF stimulation corresponded to the dynamic range of the biosensors. In order to compare
the results among themselves, each value obtained over time for every single cell, was normalized on
the average of baseline values (Figure 1C,D). When compared to EKAR, our two constructions
exhibited an increased dynamic range as shown by the normalized YFP/CFP ratios after EGF
stimulation (Figure 1C). To highlight those changes the average of baseline values was subtracted to
the average of the values upon EGF stimulation and was depicted in Figure 1E. EKAR-TVV in
particular, revealed a 21.5% FRET increase upon EGF stimulation, when EKAR-Cer-CpV and EKAR
reached respectively 19.7% and 14.2% (Figure 1C,E).
Those probes were then tested in frequency domain FLiM. As previously described, cells were
starved and then stimulated with EGF, and images were acquired every minute. Curves thus
represented the lifetime variation to the average of baseline values (Figure 1F,G). The difference
between baseline values and EGF values was also represented for each biosensor (Figure 1H).
EKAR-TVV’s dynamic range was higher than EKAR’s (160 ps and 60 ps respectively) whereas there
was no significant improvement with EKAR-Cer-CpV.
To summarize, our ERK sensor EKAR-TVV, based on the molecular recognition element of EKAR
coupled to a FRET pair composed of mTurquoise and a dimer CpVenus-Venus FPs, exhibited an
increase dynamic range in both techniques contrary to EKAR-Cer-CpV, which was improved for ratio
experiments but did not show any difference with the original sensor when tested in FLiM.
The previously reported MAPK sensor EKAREV [16] was also an improved version of EKAR
notably due to the modification of a linker within the probe. We thus choose to combine this
modification with the most efficient FRET pair to further increase the biosensors dynamic range
(Figure 1B). This third construction, named EKAREV-TVV, did not show improvement compared to
EKAR or EKAREV using ratiometric techniques (Figure 1D,E). Conversely, it strongly improved the
dynamic ranges in lifetime-based experiments compared to EKAREV (192 ps and 100 ps
respectively). Moreover EKAREV-TVV overrided EKAR-TVV performance (160 ps), making it our
best construction for lifetime experiments (Figure 1G,H).
Sensors 2014, 14 1148
Figure 1. Design and properties of ERK biosensors EKAR-Cer/CpV, EKAR-TVV and
EKAREV-TVV.
Figure 1A,B illustrates the design of new ERK biosensors. ERK DD corresponds to an ERK docking
domain (amino acid sequence: FQFP). WW is a phospho-aminoacid binding domain. The substrate
corresponds to a part of the Cdc25C sequence, coding for the amino acid sequence PDVRTPVGK
specifically recognized and phosphorylated by ERK on the Threonine 48 residue. Dotted red boxes
highlight the changes bring to the original constructions. EKAR-Cer/CpV and EKAR-TVV derive
respectively from EKAR [14] (A) and EKAREV-TVV derives from EKAREV [16] (B).
Figure 1C,D shows the YFP/CFP ratio variations upon EGF stimulation in starved HeLa cells.
EKAR-Cer/CpV (n = 43 cells) and EKAR-TVV (n = 23 cells) are compared to EKAR (n = 24 cells)
(C). EKAREV-TVV (n = 22 cells) is compared to EKAREV (n = 28 cells) (D). The histogram
Sensors 2014, 14 1149
summarizes the percentage of FRET variations upon EGF stimulation (E). Two symbols represent a
p value ≤0.01 and three symbols represent a p value ≤0.001 when compared to EKAR (circles) or
EKAREV (stars).
Figure 1F,G shows the fluorescence lifetime variations upon EGF stimulation in starved HeLa cells.
EKAR-Cer/CpV (n = 6 cells) and EKAR-TVV (n = 8 cells) are compared to EKAR (n = 7 cells) (F).
EKAREV-TVV (n = 5 cells) is compared to EKAREV (n = 4 cells) (G). The histogram sums up the
variation of the phase lifetime upon EGF stimulation (H). Three stars represent a p value ≤0.001 when
compared to EKAR or EKAREV.The YFP/CFP ratio was normalized on the average of the baseline
values (time points 0 to 6 min) for each cell (C, D). Lifetime variation was obtained by subtracting the
average of the baseline values (time points 0 to 6 min) from each time point for each cell (F, G). For
each time point either the average YFP/CFP ratio or the average delta lifetime of n cells and the
standard deviation were calculated and represented. Histograms (E, H) were calculated by subtracting
the same averages of baseline values from the average of plateau values after EGF stimulation (points
at time 12 to 20 min). p-Values were obtained using Student t-test.
The ability of the biosensor to be dephosphorylated and return to its original conformation, when
kinase activity decreases or stops, is a critical parameter. Since many kinases are regulated by negative
feedback loops or more specifically if we take the sustained/transient activation of MAPK,
a non-reversible probe would lead to wrong interpretation of physiological events, because we will be
only able to detect the first activation step. To reverse the signal, the biosensor in its folded
conformation has to allow the phosphatases to access to the phosphorylated site within the probe. We
thus tested our best construction for each technique upon inhibition of the pathway by a chemical
inhibitor of MEK, U0126 (Figures 2 and 3). Moreover, the relevance of kinase activity measurements
needed to be controlled using a negative control biosensor. We obtained this probe by site-directed
mutagenesis that replaced the phosphorylable amino acid within the substrate of the biosensor by a
non-phosphorylable residue (e.g.,: threonine replaced by an alanine). We thus used a mutated
biosensor to provide the evidence that FRET signal (increase or decrease) were not artifacts but
corresponded to conformational changes of the probe (Figures 2 and 3).
EKAR-TVV revealed the highest dynamic range in FRET ratio study. Following an EGF
stimulation cells expressing this probe, cells were exposed to the MEK inhibitor U0126. The CFP/YFP
ratio returned to a basal level when MAPK were inhibited, which demonstrated that EKAR-TVV
sensing was reversible. The variations were compared to the mutated biosensor (Figure 2A).
A representative cell expressing either EKAR-TVV or the mutated biosensor before and after drugs
addition allowed us to localize activity variations (Figure 2B). We did the same experiment in
FLiM with the sensor that exhibited in our hands the higher dynamical range for this technique:
EKAREV-TVV. As expected following an exposure to U0126, the fluorescence lifetime increased to
reach a basal level corresponding to ERK activity when cells were starved (Figure 3A). As previously
we used a mutated biosensor as control and plotted the lifetime variations for each construction on a
representative cell (Figure 3B).
Sensors 2014, 14 1150
Figure 2. Reversibility control of EKAR-TVV in ratio experiments. Curves show the
YFP/CFP ratio variations upon EGF stimulation and then inhibition of MAPK/ERK
pathway with U0126 in starved HeLa cells expressing EKAR-TVV (n = 16 cells) or a
mutated biosensor (n = 25 cells) (A). A representative cell illustrates the response of
EKAR-TVV (upper panel) and the mutant (lower panel). Cells are represented before and
after EGF stimulation and then after U0126 inhibition, in pseudo-color scale that
corresponds to ratio values. Left panel represents CFP intensity in grey level (B).
4. Conclusions
Increasing biosensor sensitivity may rely on different strategies optimizing the combination of
sensing domains (substrate and PAABD), linkers and fluorophores. Each optimization process for a
biosensor is challenging because the global dimension and topology of each of them is different, and
thus the structural requirements of each biosensor are unique. In some cases, a systematic approach,
building all the combinations of the sensors key elements might be carried out [22]. In other cases, one
can anticipate the optimal conditions and thus narrow the elements to optimize. Our approach
consisted in modifying the best available ERK activity biosensors, EKAR and EKAREV. While their
sensing component consists of a compact domain, and thus presents low structural requirements [22]
and while the linkers were previously optimized, one can predict that further optimization will rely on
the chosen donor/acceptor FRET pairs. Since monitoring FRET-based biosensors relies mainly on
fluorescence lifetime and intensity, we needed donor fluorophores with high fluorescence lifetime, and
acceptors allowing strong quenching when in close vicinity.
Sensors 2014, 14 1151
Figure 3. Reversibility control of EKAREV-TVV in FLiM experiments. Curves show the
lifetime variations upon EGF stimulation and then inhibition of MAPK/ERK pathway with
U0126 in starved HeLa cells expressing EKAREV-TVV (n = 8 cells) or a mutated
biosensor (n = 6 cells) (A). A representative cell illustrates the response of EKAREV-TVV
(upper panel) and the mutant (lower panel). Cells are represented during baseline, EGF
stimulation and U0126 inhibition, in pseudo-color scale that corresponds to fluorescence
lifetime values. Left panel represents CFP intensity in grey level (B).
Intensity and lifetime are two different properties of fluorescence. Intrinsic properties of
fluorophores will therefore increase the dynamic range, i.e., donor fluorescence lifetime for FLIM
FRET experiments or both fluorophores brightness for ratiometric measurements. Thus, these
properties can be used for a stepwise procedure of optimization of preexisting biosensors [14,16], in
contrast to random approaches, which are time-consuming [22]. However, one should not discard the
impact of other properties. One of the ideas that can be discussed relates to the fact the FRET
biosensors may also be altered by quenching-related mechanism. If one considers the impact of
conformational change on quenching, several cases may emerge: (i) quenching of donorthe dynamic
range will increase in lifetime and ratiometric measurements; (ii) quenching of acceptorthe dynamic
range of ratiometric measurements will be reduced whereas the lifetime measurements will not be
impacted; (iii) quenching of both acceptor and donorthe signal to noise ratio will be reduced and
therefore exert a strong negative impact on ratiometric measurements while the dynamic range of the
lifetime measurements will be increased. That could explain why, surprisingly, when the expected-best
FRET pair is combined to the expected-best linker, we only obtained a poor sensor for ratio
experiments compared to FLiM.
Sensors 2014, 14 1152
Several requirements necessary to achieve the best dynamic range are independent of the measured
properties of light, like the relative orientation of fluorophores. Due to the flexible nature of EKAR, it
is hard to predict this orientation in a structural point of view. Then, while we can narrow the
combination of what we identified as the best FRET pairs (CeruleanFP and mTurquoise as donors and
Cp-Venus and Cp-Venus-Venus as acceptors [17,18]) and the best linkers (72 Gly and EV linker [14,16]),
few empirical tests remained mandatory in the final optimization of such tools. We thus first tested the
most promising FRET pairs and identified the mTurquoise/CpVenus-Venus (EKAR-TVV constructs)
to give the higher dynamic range whatever the techniques. Then, we tested both available linkers in
both lifetime and intensity based experiments. Our EKAR-TVV construction shows an increased
dynamic range compared to the previous ERK biosensors EKAR and EKAREV in both ratiometric
and lifetime experiments. On the other hand EKAREV-TVV is the best sensor for FLiM experiment,
with almost 200 picoseconds of difference between inactive and active states. We were thus able to
provide new optimized constructs depending on the measurement techniques. These biosensors will be
a further milestone for a better understanding of ERK dynamics.
Acknowledgments
Pauline Vandame is funded by the University of Lille 1 and the Region Nord-Pas-de-Calais. This
work has been supported by ANR G2 Progress. We also thank Christophe Slommiany, Laurent Heliot
and the BioImaging Center Lille-Nord de France (BICeL) for the microscopy facilities. We also thank
Jin Zhang, Karel Svoboda, Jun-ichi Miyazaki, and Kees Jalink (The Nederlands Kanker Instituut) as
sources for the material. We are also grateful to Emanuele Biondi and Coralie Bompard for discussion
and comments.
Conflicts of Interest
The authors declare no conflict of interest.
References
1. Bodart, J.F. Extracellular-regulated kinase-mitogen-activated protein kinase cascade: Unsolved
issues. J. Cell Biochem. 2010, 109, 850857.
2. Wang, R.; He, G.; Nelman-Gonzalez, M.; Ashorn, C.L.; Gallick, G.E.; Stukenberg, P.T.;
Kirschner, M.W.; Kuang, J. Regulation of Cdc25C by ERK-MAP kinases during the G2/M
transition. Cell 2007, 128, 11191132.
3. Yoon, S.; Seger, R. The extracellular signal-regulated kinase: Multiple substrates regulate diverse
cellular functions. Growth Factors 2006, 24, 2144.
4. Santos, S.D.; Verveer, P.J.; Bastiaens, P.I. Growth factor-induced MAPK network topology
shapes Erk response determining PC-12 cell fate. Nat. Cell Biol. 2007, 9, 324330.
5. Ferrell, J.E., Jr.; Machleder, E.M. The biochemical basis of an all-or-none cell fate switch in
Xenopus oocytes. Science 1998, 280, 895898.
Sensors 2014, 14 1153
6. Beaujois, R.; Riquet, F.; Cailliau, K.; Browayes, E.; Russo, C.; Blossey, R.; Vicogne, D.;
Marin, M.; Lescuyer-Rousseau, A.; Vilain, J.P.; et al. Ultrasensitive MAPK/Erk activation in
absence of protein synthesis in Xenopus oocytes. MAP Kinase 2013, 2, 19.
7. Russo, C.; Giuraniuc, C.; Blossey, R.; Bodart, J.F. On the equilibria of the MAPK cascade:
Cooperativity, modularity and bistability. Phys. A Stat. Mech. Appl 2009, 388, 50705080.
8. Pullikuth, A.K.; Catling, A.D. Scaffold mediated regulation of MAPK signaling and cytoskeletal
dynamics: A perspective. Cell Signal 2007, 19, 16211632.
9. Sipieter, F.; Vandame, P.; Spriet, C.; Leray, A.; Vincent, P.; Trinel, D.; Bodart, J.F.; Riquet, F.B.;
Heliot, L. From FRET imaging to practical methodology for kinase activity sensing in living cells.
Prog. Mol. Biol. Transl. Sci. 2013, 113, 145216.
10. Kardash, E.; Bandemer, J.; Raz, E. Imaging protein activity in live embryos using fluorescence
resonance energy transfer biosensors. Nat. Protoc. 2011, 6, 18351846.
11. Fujioka, A.; Terai, K.; Itoh, R.E.; Aoki, K.; Nakamura, T.; Kuroda, S.; Nishida, E.; Matsuda, M.
Dynamics of the Ras/ERK MAPK cascade as monitored by fluorescent probes. J. Biol. Chem.
2006, 281, 89178926.
12. Tsuboi, Y.; Ichida, T.; Sugitani, S.; Genda, T.; Inayoshi, J.; Takamura, M.; Matsuda, Y.; Nomoto, M.;
Aoyagi, Y. Overexpression of extracellular signal-regulated protein kinase and its correlation with
proliferation in human hepatocellular carcinoma. Liver Int. 2004, 24, 432436.
13. Sato, M.; Kawai, Y.; Umezawa, Y. Genetically encoded fluorescent indicators to visualize protein
phosphorylation by extracellular signal-regulated kinase in single living cells. Anal. Chem. 2007,
79, 25702575.
14. Harvey, C.D.; Ehrhardt, A.G.; Cellurale, C.; Zhong, H.; Yasuda, R.; Davis, R.J.; Svoboda, K.
A genetically encoded fluorescent sensor of ERK activity. Proc. Nat. Acad. Sci. USA 2008, 105,
1926419269.
15. Eymin, B.; Claverie, P.; Salon, C.; Brambilla, C.; Brambilla, E.; Gazzeri, S. p14ARF triggers
G2 arrest through ERK-mediated Cdc25C phosphorylation, ubiquitination and proteasomal
degradation. Cell Cycle 2006, 5, 759765.
16. Komatsu, N.; Aoki, K.; Yamada, M.; Yukinaga, H.; Fujita, Y.; Kamioka, Y.; Matsuda, M.
Development of an optimized backbone of FRET biosensors for kinases and GTPases. Mol. Biol.
Cell 2011, 22, 46474656.
17. Klarenbeek, J.B.; Goedhart, J.; Hink, M.A.; Gadella, T.W.; Jalink, K. A mTurquoise-based cAMP
sensor for both FLIM and ratiometric read-out has improved dynamic range. PLoS One 2011, 6,
e19170.
18. Depry, C.; Allen, M.D.; Zhang, J. Visualization of PKA activity in plasma membrane
microdomains. Mol. Biosyst. 2011, 7, 5258.
19. Allen, M.D.; Zhang, J. Subcellular dynamics of protein kinase a activity visualized by
FRET-based reporters. Biochem. Biophys. Res. Commun. 2006, 348, 716721.
20. Goedhart, J.; van Weeren, L.; Hink, M.A.; Vischer, N.O.; Jalink, K.; Gadella, T.W., Jr. Bright
cyan fluorescent protein variants identified by fluorescence lifetime screening. Nat. Methods
2010, 7, 137139.
Sensors 2014, 14 1154
21. Kremers, G.J.; Goedhart, J.; van Munster, E.B.; Gadella, T.W., Jr. Cyan and yellow super
fluorescent proteins with improved brightness, protein folding, and FRET Forster radius.
Biochemistry 2006, 45, 65706580.
22. Fritz, R.D.; Letzelter, M.; Reimann, A.; Martin, K.; Fusco, L.; Ritsma, L.; Ponsioen, B.; Fluri, E.;
Schulte-Merker, S.; van Rheenen, J.; et al. A versatile toolkit to produce sensitive FRET
biosensors to visualize signaling in time and space. Sci. Signal 2013, 6, 12.
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article
distributed under the terms and conditions of the Creative Commons Attribution license
(http://creativecommons.org/licenses/by/3.0/).
... Nevertheless, biological based biosensors can be common only defined as biological items, whose properties modifications upon environmental modifications can be measured. Herein this opinion article we will refer only to biosensors as the biological based ones, which cover [1] molecules : among the best characterized biosensors are the FRET (Förster Resonance Energy Transfer)-based, genetically encoded Kinase Activity Reporter (KAR) [1,2], (2) cells : CBB (Cells Based Biosensors; [3] and (3) organisms, like Xenopus embryos, whose development is sensitive to external factors (FETAX), Frog Embryo Teratogenesis Assay Xenopus [4] ( Figure 1A). ...
... Nevertheless, biological based biosensors can be common only defined as biological items, whose properties modifications upon environmental modifications can be measured. Herein this opinion article we will refer only to biosensors as the biological based ones, which cover [1] molecules : among the best characterized biosensors are the FRET (Förster Resonance Energy Transfer)-based, genetically encoded Kinase Activity Reporter (KAR) [1,2], (2) cells : CBB (Cells Based Biosensors; [3] and (3) organisms, like Xenopus embryos, whose development is sensitive to external factors (FETAX), Frog Embryo Teratogenesis Assay Xenopus [4] ( Figure 1A). ...
... Difficulties at this level . For details about acquisition and analysis procedure, see [1,2]. are no longer technical. ...
Article
As an incipit, one has to define the term biosensor. The term has been enclosing several views and concepts, which we will not review here. Nevertheless, biological based biosensors can be common only defined as biological items, whose properties modifications upon environmental modifications can be measured. Herein this opinion article we will refer only to biosensors as the biological based ones, which cover [1] molecules : among the best characterized biosensors are the FRET (Förster Resonance Energy Transfer)-based, genetically encoded Kinase Activity Reporter (KAR) [1,2], (2) cells : CBB (Cells Based Biosensors; [3] and (3) organisms, like Xenopus embryos, whose development is sensitive to external factors (FETAX), Frog Embryo Teratogenesis Assay Xenopus [4] (Figure 1A).The untangling of complex signalling network is imperative both for understanding cells and organisms physiological and pathological contexts, and for isolating the ideal property modifications to measure that will reflect, for example, the deregulation of these networks. These modifications are the one seeked for biosensors design or choice. Then, biosensors become mandatory for deciphering and characterizing molecular signatures associated with pathologies. The latter aspect is naturally tightly linked to prognosis and diagnosis.
... There have been multiple improvements to EKAR since its initial inception [12], including changes to the linker length [13], usage of brighter and more pH-stable CFP and YFP variants [14], and changes in FP position. Recent iterations of EKAR, EKAREN4 and EKAREN5, addressed the non-specific phosphorylation of the biosensor by CDK1, which causes non-ERK specific signals in G2/M phases of the cell cycle [15]. ...
... Accordingly, a more general form of the FRET measurement model was necessary to account for spectral cross-talk terms. Working from the imaging system model presented in the "FRET reporter measurement and correction" section of the appendix to [14] (eqns. 1-3), we model the intensity ratio of the FRET720 imaging channel to the RFP670 channel as: ...
Preprint
Full-text available
Cell fate decisions are regulated by intricate signaling networks, with Extracellular signal-Regulated Kinase (ERK) being a central regulator. However, ERK is rarely the only signaling pathway involved, creating a need to study multiple signaling pathways simultaneously at the single-cell level. Many existing fluorescent biosensors for ERK and other pathways have significant spectral overlap, limiting their ability to be multiplexed. To address this limitation, we developed two novel red-FRET ERK biosensors, REKAR67 and REKAR76, which operate in the 670-720 nm range using miRFP670nano3 and miRFP720. REKAR67 and REKAR76 differ in fluorophore position, which impacts biosensor characteristics; REKAR67 displayed a higher dynamic range but greater signal variance than REKAR76. Mixed populations of REKAR67 or REKAR76 displayed similar Signal-to-Noise ratio (SNR), but in clonal cell populations, REKAR76 had a significantly higher SNR. Overall, our red-FRET ERK biosensors were highly consistent with existing ERK FRET biosensors and in reporting ERK activity and are spectrally compatible with CFP/YFP FRET and cpGFP -based biosensors. Both REKAR biosensors expand the available methods for measuring single-cell ERK activity.
... Testing two of the various versions of ERK1/2 FRET biosensors, EKAR-EV (Komatsu et al., 2011) and EKAR-EV-TVV (Vandame et al., 2014) in HeLa and L929 cells ( Figures 3B and S4A), we observed that the ratio decrease reported by these biosensors upon ERK1/2 inhibition was relatively slow, and therefore poorly efficient in reporting ERK1/2 activity decrease (i.e., biosensor dephosphorylation), as already mentioned in the literature (Regot et al., 2014). We reasoned that the obligated linker composition required for KAR engineering (Table S1) resulting from the recombination cloning method (MultiSite Gateway Technology) (Jones et al., 2014) might alleviate this shortcoming by adding flexibility. ...
... At the time, a comparison in HeLa cells of EKAR4.0 to others FRET biosensors for monitoring ERK1/2 activity from the same design, except EKAR3 (Sparta et al., 2015), showed EKAR4.0 to overall perform better ( Figures S6A-S6G). Of note, when compared to EKAR-EV (Komatsu et al., 2011) and t-EKAR-EV-vv (Vandame et al., 2014), EKAR4.0 also performed better in L929 cells ( Figure S4A). ...
Article
Full-text available
ERK1/2 involvement in cell death remains unclear, although many studies have demonstrated the importance of ERK1/2 dynamics in determining cellular responses. To untangle how ERK1/2 contributes to two cell death programs, we investigated ERK1/2 signaling dynamics during hFasL-induced apoptosis and TNF-induced necroptosis in L929 cells. We observed that ERK1/2 inhibition sensitizes cells to apoptosis while delaying necroptosis. By monitoring ERK1/2 activity by live-cell imaging using an improved ERK1/2 biosensor (EKAR4.0), we reported differential ERK1/2 signaling dynamics between cell survival, apoptosis, and necroptosis. We also decrypted a temporally shifted amplitude- and frequency-modulated (AM/FM) ERK1/2 activity profile in necroptosis versus apoptosis. ERK1/2 inhibition, which disrupted ERK1/2 signaling dynamics, prevented TNF and IL-6 gene expression increase during TNF-induced necroptosis. Using an inducible cell line for activated MLKL, the final executioner of necroptosis, we showed ERK1/2 and its distinctive necroptotic ERK1/2 activity dynamics to be positioned downstream of MLKL.
... For example, the FRET reporter EKAR3 shows greater sensitivity than ERK-KTR to small ERK activity changes but saturates easily [51]. While the dynamic range of FRET-based reporters has increased [48,53], a head-to-head comparison between the newest FRET reporters and translocation reporters to assess their relative advantages has not yet been performed. Altogether, these differences emphasize the caveat that the amplitude of ERK reporter signals must be interpreted with caution and not as an absolute linear measurement. ...
Article
Full-text available
Extracellular signal-regulated kinase (ERK) has long been studied as a key driver of both essential cellular processes and disease. A persistent question has been how this single pathway is able to direct multiple cell behaviors, including growth, proliferation, and death. Modern biosensor studies have revealed that the temporal pattern of ERK activity is highly variable and heterogeneous, and critically, that these dynamic differences modulate cell fate. This two-part review discusses the current understanding of dynamic activity in the ERK pathway, how it regulates cellular decisions, and how these cell fates lead to tissue regulation and pathology. In part 1, we cover the optogenetic and live-cell imaging technologies that first revealed the dynamic nature of ERK, as well as current challenges in biosensor data analysis. We also discuss advances in mathematical models for the mechanisms of ERK dynamics, including receptor-level regulation, negative feedback, cooperativity, and paracrine signaling. While hurdles still remain, it is clear that higher temporal and spatial resolution provide mechanistic insights into pathway circuitry. Exciting new algorithms and advanced computational tools enable quantitative measurements of single-cell ERK activation, which in turn inform better models of pathway behavior. However, the fact that current models still cannot fully recapitulate the diversity of ERK responses calls for a deeper understanding of network structure and signal transduction in general.
... AC-activation sensors are available [309], as well as sensors monitoring fluctuations of intracellular second messengers like cAMP [310,311], IP1 [312] and calcium [313,314]. Additionally, there are FRET sensors available for further downstream effectors such as ERK [315,316]. ...
Thesis
Full-text available
Cyclic adenosine monophosphate (cAMP), the ubiquitous second messenger produced upon stimulation of GPCRs which couple to the stimulatory GS protein, orchestrates an array of physiological processes including cardiac function, neuronal plasticity, immune responses, cellular proliferation and apoptosis. By interacting with various effector proteins, among others protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac), it triggers signaling cascades for the cellular response. Although the functional outcomes of GSPCR-activation are very diverse depending on the extracellular stimulus, they are all mediated exclusively by this single second messenger. Thus, the question arises how specificity in such responses may be attained. A hypothesis to explain signaling specificity is that cellular signaling architecture, and thus precise operation of cAMP in space and time would appear to be essential to achieve signaling specificity. Compartments with elevated cAMP levels would allow specific signal relay from receptors to effectors within a micro- or nanometer range, setting the molecular basis for signaling specificity. Although the paradigm of signaling compartmentation gains continuous recognition and is thoroughly being investigated, the molecular composition of such compartments and how they are maintained remains to be elucidated. In addition, such compartments would require very restricted diffusion of cAMP, but all direct measurements have indicated that it can diffuse in cells almost freely. In this work, we present the identification and characterize of a cAMP signaling compartment at a GSPCR. We created a Förster resonance energy transfer (FRET)-based receptor-sensor conjugate, allowing us to study cAMP dynamics in direct vicinity of the human glucagone-like peptide 1 receptor (hGLP1R). Additional targeting of analogous sensors to the plasma membrane and the cytosol enables assessment of cAMP dynamics in different subcellular regions. We compare both basal and stimulated cAMP levels and study cAMP crosstalk of different receptors. With the design of novel receptor nanorulers up to 60nm in length, which allow mapping cAMP levels in nanometer distance from the hGLP1R, we identify a cAMP nanodomain surrounding it. Further, we show that phosphodiesterases (PDEs), the only enzymes known to degrade cAMP, are decisive in constraining cAMP diffusion into the cytosol thereby maintaining a cAMP gradient. Following the discovery of this nanodomain, we sought to investigate whether downstream effectors such as PKA are present and active within the domain, additionally studying the role of A-kinase anchoring proteins (AKAPs) in targeting PKA to the receptor compartment. We demonstrate that GLP1-produced cAMP signals translate into local nanodomain-restricted PKA phosphorylation and determine that AKAP-tethering is essential for nanodomain PKA. Taken together, our results provide evidence for the existence of a dynamic, receptor associated cAMP nanodomain and give prospect for which key proteins are likely to be involved in its formation. These conditions would allow cAMP to exert its function in a spatially and temporally restricted manner, setting the basis for a cell to achieve signaling specificity. Understanding the molecular mechanism of cAMP signaling would allow modulation and thus regulation of GPCR signaling, taking advantage of it for pharmacological treatment.
... EKAR is composed of a YFP, WW domain, Gly linker, ERK phosphorylated peptide containing ERK docking motif, and CFP, and exhibits an increase in FRET by the phosphorylation (Fig. 2B). Following the initial report of EKAR, several researchers have reported improvements of this biosensor (Fig. 2C), either by using a long flexible linker and dimerization-prone fluorescent protein pair (EKAREV) (Komatsu et al., 2011), or optimization of fluorescent proteins and the order of domains (EKAR2G, EKAR-TVV, EKAR3, EKAR4) (Fritz et al., 2013;Vandame et al., 2014;Sparta et al., 2015;Keyes et al., 2020). These improvements have significantly enhanced the gain of the FRET signal, allowing more researchers to easily employ the FRET biosensors. ...
Article
The extracellular signal-regulated kinase (ERK) pathway governs cell proliferation, differentiation and migration, and therefore plays key roles in various developmental and regenerative processes. Recent advances in genetically encoded fluorescent biosensors have unveiled hitherto unrecognized ERK activation dynamics in space and time and their functional importance mainly in cultured cells. However, ERK dynamics during embryonic development have still only been visualized in limited numbers of model organisms, and we are far from a sufficient understanding of the roles played by developmental ERK dynamics. In this Review, we first provide an overview of the biosensors used for visualization of ERK activity in live cells. Second, we highlight the applications of the biosensors to developmental studies of model organisms and discuss the current understanding of how ERK dynamics are encoded and decoded for cell fate decision-making.
Article
Full-text available
Cellular function is controlled through intricate networks of signals, which lead to the myriad pathways governing cell fate. Fluorescent biosensors have enabled the study of these signaling pathways in living systems across temporal and spatial scales. Over the years there has been an explosion in the number of fluorescent biosensors, as they have become available for numerous targets, utilized across spectral space, and suited for various imaging techniques. To guide users through this extensive biosensor landscape, we discuss critical aspects of fluorescent proteins for consideration in biosensor development, smart tagging strategies, and the historical and recent biosensors of various types, grouped by target, and with a focus on the design and recent applications of these sensors in living systems.
Article
Genetically encoded, fluorescent protein (FP)‐based Förster resonance energy transfer (FRET) biosensors are microscopy imaging tools tailored for the precise monitoring and detection of molecular dynamics within subcellular microenvironments. They are characterised by their ability to provide an outstanding combination of spatial and temporal resolutions in live‐cell microscopy. In this review, we begin by tracing back on the historical development of genetically encoded FP labelling for detection in live cells, which lead us to the development of early biosensors and finally to the engineering of single‐chain FRET‐based biosensors that have become the state‐of‐the‐art today. Ultimately, this review delves into the fundamental principles of FRET and the design strategies underpinning FRET‐based biosensors, discusses their diverse applications and addresses the distinct challenges associated with their implementation. We place particular emphasis on single‐chain FRET biosensors for the Rho family of guanosine triphosphate hydrolases (GTPases), pointing to their historical role in driving our understanding of the molecular dynamics of this important class of signalling proteins and revealing the intricate relationships and regulatory mechanisms that comprise Rho GTPase biology in living cells.
Article
Nowadays, numerous domains such as biology, physiology, environmental sciences, and pharmacology, have made extensive use of fluorescence sensors for ions and neutral analytes. Fluorescence sensors have been developed for roughly 150 years. A varied assortment of fluorescence sensors has been developed recently for the identification of species that are significant to biology and the environment. Despite the advancements in this area, a number of issues and difficulties persist. This review discusses the history and offers a broad outline of the progress in the study of fluorescence sensors, often known as sensors. This will be accomplished by emphasizing a few innovative and exemplary works from numerous international groups that have made significant contributions to this field. The fundamental ethical considerations elaborate in developing sensors for particular analytes, problems and roadblocks encountered in the field, and potential future research avenues are all explored. The future of sensor technology is quite promising in both established and new technologies.
Article
The RAF-MEK-ERK mitogen-activated protein kinase (MAPK) cascade is aberrantly activated in a diverse set of human cancers and the RASopathy group of genetic developmental disorders. This protein kinase cascade is one of the most intensely studied cellular signaling networks and has been frequently targeted by the pharmaceutical industry, with more than 30 inhibitors either approved or under clinical evaluation. The ERK-MAPK cascade was originally depicted as a serial and linear, unidirectional pathway that relays extracellular signals, such as mitogenic stimuli, through the cytoplasm to the nucleus. However, we now appreciate that this three-tiered protein kinase cascade is a central core of a complex network with dynamic signaling inputs and outputs and autoregulatory loops. Despite our considerable advances in understanding the ERK-MAPK network, the ability of cancer cells to adapt to the inhibition of key nodes reveals a level of complexity that remains to be fully understood. In this review, we summarize important developments in our understanding of the ERK-MAPK network and identify unresolved issues for ongoing and future study.
Article
Full-text available
The mitogen-activated protein kinase (MAPK) cascade in Xenopus oocytes exhibits an all-or-none, ultrasensitive response, which is believed to result from a positive feed-back loop. Here we describe a context where 1,10-phenan-throline slowly, but strongly, activates MAPK while it impairs protein synthesis in a zinc-dependent manner, abolishing any feed-back loop. The induced-MAPK response was found to be strongly ultrasensitive. We argue that under-lying this behaviour is a regulation motif akin to a feed-forward loop acting in vivo.
Article
Full-text available
Genetically encoded, ratiometric biosensors based on fluorescence resonance energy transfer (FRET) are powerful tools to study the spatiotemporal dynamics of cell signaling. However, many biosensors lack sensitivity. We present a biosensor library that contains circularly permutated mutants for both the donor and acceptor fluorophores, which alter the orientation of the dipoles and thus better accommodate structural constraints imposed by different signaling molecules while maintaining FRET efficiency. Our strategy improved the brightness and dynamic range of preexisting RhoA and extracellular signal-regulated protein kinase (ERK) biosensors. Using the improved RhoA biosensor, we found micrometer-sized zones of RhoA activity at the tip of F-actin bundles in growth cone filopodia during neurite extension, whereas RhoA was globally activated throughout collapsing growth cones. RhoA was also activated in filopodia and protruding membranes at the leading edge of motile fibroblasts. Using the improved ERK biosensor, we simultaneously measured ERK activation dynamics in multiple cells using low-magnification microscopy and performed in vivo FRET imaging in zebrafish. Thus, we provide a construction toolkit consisting of a vector set, which enables facile generation of sensitive biosensors.
Article
Full-text available
Fluorescence resonance energy transfer (FRET)-based molecular biosensors serve as important tools for studying protein activity in live cells and have been widely used for this purpose over the past decade. However, FRET biosensors are rarely used in the context of the live organism because of the inherent high cellular complexity and imaging challenges associated with the three-dimensional environment. Here we provide a protocol for using single-chain intramolecular FRET-based biosensors in early development. We provide a general protocol for FRET ratio imaging in embryos, including the data-acquisition conditions and the algorithm for ratio image generation. We then use the pRaichu RacFRET biosensor to exemplify the adaptation and optimization of a particular biosensor for use in live zebrafish embryos. Once an optimized biosensor is available, the complete procedure, including introduction of the probes into embryos, imaging and data analysis, requires 2-3 d.
Article
Full-text available
Biosensors based on the principle of Förster (or fluorescence) resonance energy transfer (FRET) have shed new light on the spatiotemporal dynamics of signaling molecules. Among them, intramolecular FRET biosensors have been increasingly used due to their high sensitivity and user-friendliness. Time-consuming optimizations by trial and error, however, obstructed the development of intramolecular FRET biosensors. Here we report an optimized backbone for rapid development of highly sensitive intramolecular FRET biosensors. The key concept is to exclude the "orientation-dependent" FRET and to render the biosensors completely "distance-dependent" with a long, flexible linker. We optimized a pair of fluorescent proteins for distance-dependent biosensors, and then developed a long, flexible linker ranging from 116 to 244 amino acids in length, which reduced the basal FRET signal and thereby increased the gain of the FRET biosensors. Computational simulations provided insight into the mechanisms by which this optimized system was the rational strategy for intramolecular FRET biosensors. With this backbone system, we improved previously reported FRET biosensors of PKA, ERK, JNK, EGFR/Abl, Ras, and Rac1. Furthermore, this backbone enabled us to develop novel FRET biosensors for several kinases of RSK, S6K, Akt, and PKC and to perform quantitative evaluation of kinase inhibitors in living cells.
Article
Full-text available
FRET-based sensors for cyclic Adenosine Mono Phosphate (cAMP) have revolutionized the way in which this important intracellular messenger is studied. The currently prevailing sensors consist of the cAMP-binding protein Epac1, sandwiched between suitable donor- and acceptor fluorescent proteins (FPs). Through a conformational change in Epac1, alterations in cellular cAMP levels lead to a change in FRET that is most commonly detected by either Fluorescence Lifetime Imaging (FLIM) or by Sensitized Emission (SE), e.g., by simple ratio-imaging. We recently reported a range of different Epac-based cAMP sensors with high dynamic range and signal-to-noise ratio. We showed that constructs with cyan FP as donor are optimal for readout by SE, whereas other constructs with green FP donors appeared much more suited for FLIM detection. In this study, we present a new cAMP sensor, termed (T)Epac(VV), which employs mTurquoise as donor. Spectrally very similar to CFP, mTurquoise has about doubled quantum efficiency and unlike CFP, its fluorescence decay is strictly single-exponential. We show that (T)Epac(VV) appears optimal for detection both by FLIM and SE, that it has outstanding FRET span and signal-to-noise ratio, and improved photostability. Hence, (T)Epac(VV) should become the cAMP sensor of choice for new experiments, both for FLIM and ratiometric detection.
Article
Biological processes are intrinsically dynamic. Although traditional methods provide valuable insights for the understanding of many biological phenomena, the possibility of measuring, quantifying, and localizing proteins within a cell, a tissue, and even an embryo has revolutionized our train of thoughts and has encouraged scientists to develop molecular tools for the assessment of protein or protein complex dynamics within their physiological context. These ongoing efforts rest on the emergence of biophotonic techniques and the continuous improvement of fluorescent probes, allowing precise and reliable measurements of dynamic cellular functions. The march of the "in vivo biochemistry" has begun, already yielding breathtaking results.
Article
The ubiquitous Protein Kinase A (PKA) signaling pathway is responsible for the regulation of numerous processes including gene expression, metabolism, cell growth, and cell proliferation. This method details how to monitor real-time PKA activity dynamics in mammalian cells using fluorescence resonance energy transfer (FRET)-based reporters.
Article
Xenopus oocytes convert a continuously variable stimulus, the concentration of the maturation-inducing hormone progesterone, into an all-or-none biological response-oocyte maturation. Here evidence is presented that the all-or-none character of the response is generated by the mitogen-activated protein kinase (MAPK) cascade. Analysis of individual oocytes showed that the response of MAPK to progesterone or Mos was equivalent to that of a cooperative enzyme with a Hill coefficient of at least 35, more than 10 times the Hill coefficient for the binding of oxygen to hemoglobin. The response can be accounted for by the intrinsic ultrasensitivity of the oocyte's MAPK cascade and a positive feedback loop in which the cascade is embedded. These findings provide a biochemical rationale for the all-or-none character of this cell fate switch.
Article
Membrane rafts are sphingolipid- and cholesterol-rich microdomains that contain dynamic arrangements of signaling proteins. Notably, various components of the ubiquitous cAMP/Protein Kinase A (PKA) pathway, including β-adrenergic receptors (β-ARs), G proteins, and adenylyl cyclases (ACs), have been shown to localize differentially between membrane rafts and non-raft regions of the plasma membrane. As PKA participates in regulating diverse fundamental cellular functions, a number of which require membrane rafts, it is important to understand how PKA activity is specifically regulated in these membrane microdomains. To this end, we developed an improved FRET-based PKA activity biosensor, and targeted it to both membrane raft and non-raft regions of the plasma membrane to examine PKA activity dynamics in different plasma membrane microdomains. Disruption of membrane rafts via cholesterol depletion was shown to enhance β-AR stimulated PKA activity at the plasma membrane, suggesting that membrane rafts play a negative role in β-AR stimulated PKA activation. Furthermore, we found that membrane rafts possess higher basal PKA activity in the resting state compared to non-raft regions, which depends on the integrity of membrane rafts and proper localization of PKA. This study shows that membrane rafts play an important role in regulating the activity of PKA at the plasma membrane, and demonstrates the ability of live-cell FRET-based assays to reveal dynamic differences amongst plasma membrane microdomains, laying a foundation for further dissection of membrane regulated signal transduction.
Article
This review point out several aspects regarding the mitogen-activated protein kinase (MAPK)/extracellular-regulated kinase (Erk) network, which are still pending issues in the understanding how this pathway integrate information to drive cell fates. Focusing on the role of Erk during cell cycle, it has to be underlined that Erk downstream effectors, which are required for mitosis progression and contribute to aneuploidy during tumorigenesis, remain to be determined. In addition to the identity of the terminal enzymes or effectors of Erk, it has to be stressed that the dynamic nature of the Erk signal is itself a key factor in cell phenotype decisions. Development of biophotonics strategies for monitoring the Erk network at the spatiotemporal level in living cells, as well as computational and hypothesis-driven approaches, are called to unravel the principles by which signaling networks create biochemical and biological specificities. Finally, Erk dynamics might also be impacted by other post-translational modification than phosphorylation, such as O-GlcNAcylation.